New hepatitis A vaccines and their role in prevention

Drugs

Volumn 51, Issue 3, 1996, Pages 359-366

  Strader, Doris B ^a,b   Seeff, Leonard B ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN; INACTIVATED VACCINE; LIVE VACCINE;

ANOREXIA; ARMY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DAY CARE; DEVELOPING COUNTRY; FATIGUE; FEVER; HEADACHE; HEALTH CARE PERSONNEL; HEPATITIS A; HEPATITIS A VIRUS; HOMOSEXUALITY; HOUSEHOLD; HUMAN; HYGIENE; IMMUNOGENICITY; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ABUSE; MALAISE; NAUSEA; NONHUMAN; PASSIVE IMMUNIZATION; PREVALENCE; REVIEW; RISK FACTOR; SIDE EFFECT; TRAVEL; VACCINE PRODUCTION; VIRUS TRANSMISSION;

EID: 0029879414     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199651030-00002     Document Type: Review

References (25)

1. Sherlock S, Dooley J. Viral hepatitis. In: Sherlock S, Dolley J, editors. Diseases of the liver and biliary system. Oxford: Blackwell Scientific Publications, 1993: 260-93
2. Wagner G, Lavanchy D, Darioli R, et al. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers. Vaccine 1993; 11 (10): 1027-32
3. Schiff E. Atypical manifestations of hepatitis A. Vaccine 1992; 10 Suppl. 1: S18-20
4. Chiriaco P, Guadalupi C, Armigliato M, et al. Polyphasic course of hepatitis type A in children. J Infect Dis 1986; 153: 378-9
5. Sjögren NH, Tanno H, Fay O, et al. Hepatitis A virus in stool during clinical relapse. Ann Intern Med 1987; 106: 221-6
6. Siegl G, Lemon SM. Recent advances in hepatitis A vaccine development. Virus Res 1990; 17: 75-92
7. Francis DP, Hadler SC, Prendergast TJ, et al. Occurrence of hepatitis A, B, and non-A, non-B in the United States: CDC sentinel county hepatitis study I. Am J Med 1984; 76: 69-74
8. Hadler SC. Global pattern of hepatitis A virus infection changing patterns. In: Hollinger FB, Lemon SM, Margolis H, editors. Viral hepatitis and liver disease. Baltimore (MD): Williams & Wilkins, 1991; 14-20
9. Weiland O, Niklasson B, Berg R, et al. Clinical and subclinical hepatitis A occurring after immunoglobulin prophylaxis among Swedish UN soldiers in Sinai. Scand J Gastroenterol 1981; 16: 967-72
10. Outbreak of hepatitis C associated with intravenous immunoglobulin administration: United States, October 1993-June 1994. MMWR Morb Mortal Wkly Rep 1994; 43: 505-9
11. Andre F, Hepburn A, D'Hondt E. Inactivated candidate vaccines for hepatitis A. Prog Med Virol 1990; 37: 72-95
12. Provost PJ, Banker FS, Giesa PA, et al. Progress toward a live, attenuated human hepatitis A vaccine. Proc Soc Exp Biol Med 1982; 170: 8-14
13. Karron RA, Daemer RJ, Ticehurst JR, et al. Studies of prototype live hepatitis A virus vaccine in primate models. J Infect Dis 1988; 157: 338-45
14. Jansen RW, Newbold JE, Lemon SM. Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology 1988; 163: 299-307
15. Provost PJ, Hilleman MR. An inactivated hepatitis A virus vaccine prepared from infected marmoset liver. Proc Soc Exp Biol Med 1978; 159: 201-3
16. Gust ID, Feinstone SM. Hepatitis A. Boca Raton (LA): CRC Press, Inc., 1988
17. Werzberger A, Mensch B, Kuter B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327: 453-7
18. Innis BL, Snitbhan R, Kunasol P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994; 271: 1328-34
19. Shouval D, Ashur Y, Adler R, et al. Single and booster dose responses to an inactivated hepatitis A vaccine: comparison with immune serum globulin prophylaxis. Vaccine 1993; 11 Suppl. 1: S9-14
20. Westblom TU, Gudipati S, DeRousse C, et al. Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule. J Infect Dis 1994; 169: 996-1001
21. Green MS, Cohen D, Lerman Y, et al. Depression of the immune response to an inactivate hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis 1993; 168: 740-3
22. Bryan JP, Nelson M. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines. Arch Int Med 1994; 154: 663-8
23. Advisory Committee on Immunisation Procedures. Licensure of inactivated hepatitis A vaccine and recommendations for use among international travellers. MMWR Morb Mortal Wkly Rep 1995 Jul 28; 44 (29): 559-60
24. Santagostino E, Gingeri A, Rocino A, et al. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophiliac patients. Thromb Haemostas 1994; 72: 508-10
25. Rothschild C, Pol S, Mattlinger B, et al. Vaccination against hepatitis A in French hemophilic children. Vox Sang 1995; 69: 80-1